Association of Factor V Leiden G1691a in Women Suffering Repeated Abortions | ||
| Minia Journal of Medical Research | ||
| Volume 31, Issue 1, January 2020, Pages 36-42 PDF (328.31 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/mjmr.2022.221387 | ||
| Authors | ||
| Asmaa kh. Ezz Eldein; Esmat A. El Sharkawy; Khalid M. Salah; Ayman G. Ghobrial; Aliaa M. Ali Higazi | ||
| Department of Clinical Pathology, Faculty of Medicine -Minia University | ||
| Abstract | ||
| Purpose: To assess the relationship of factor V leiden G1691A mutation as a risk factor for repeated pregnancy loss. The focus has been on factor V leiden G1691A mutation that may predispose women to microthrombosis during the stages of embryo implantation and placentation. Methods: A total of 70 women with recurrent pregnancy loss, mean age 31.1±4.2 years, were involved in the study. As a control group, 70 women [mean age 32.2±3.3 years with at least two live-born child and no history of abortion were included. We used real-time polymerase chain reaction (PCR) to determine the frequencies of factor V leiden G1691A genotype. Results: The frequency of heterozygotes for factor V leiden G1691A was significantly higher in women with repeated pregnancy loss compared to women without abortion (p = 0.0001). Conclusion: In summary we found an association of factor V leiden G1691A mutation with recurrent pregnancy loss .We recommend for factor V leiden G1691A screening in cases with repeated pregnancy loss so they can start anticoagulant therapy more earlier. | ||
| Keywords | ||
| G1691A; factor V leiden; pregnancy; abortion | ||
|
Supplementary Files
|
||
|
Statistics Article View: 144 PDF Download: 318 |
||
